Insider · CIK 0001704342
Martin Wilson
Files at RCKT (ROCKET PHARMACEUTICALS, INC.). First filing Nov 25, 2024, latest Sep 15, 2026.
In brief
Martin Wilson files SEC Form 4 as officer at RCKT (ROCKET PHARMACEUTICALS, INC.). Since Nov 25, 2024, Martin Wilson has reported 0 open-market buys worth $0 and 13 open-market sells worth $401k, the latest filed on Sep 15, 2026.
A track record needs three past buys with six months of prices behind them; Martin Wilson has 0, so none is measured yet.
The newest scored trade: sold $256k of RCKT on Sep 11, 2026, filed Sep 15, 2026, scored 33 (weak). In the last 12 months: 0 buys worth $0 and 8 sells worth $335k.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
RCKT: ROCKET PHARMACEUTICALS, INC.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 33Weak | RCKTsell ROCKET PHARMACEUTICALS, INC. | $256k 75,364 shares | -11% | - | |
| 30Weak | ROCKET PHARMACEUTICALS, INC. | $2,133 631 shares | -0% | +28% from low-37% from high | |
| 30Weak | ROCKET PHARMACEUTICALS, INC. | $12k 3,493 shares | -1% | +28% from low-37% from high | |
| 30Weak | ROCKET PHARMACEUTICALS, INC. | $1,995 662 shares | -0% | +25% from low-57% from high | |
| 30Weak | ROCKET PHARMACEUTICALS, INC. | $12k 3,361 shares | -0% | +55% from low-47% from high | |
| 30Weak | ROCKET PHARMACEUTICALS, INC. | $4,593 1,376 shares | -0% | +48% from low-68% from high | |
| 36Weak | ROCKET PHARMACEUTICALS, INC. | $41k 12,253 shares | -2% | +40% from low-70% from high | |
| 30Weak | ROCKET PHARMACEUTICALS, INC. | $4,910 1,646 shares | -0% | +26% from low-80% from high | |
| 30Weak | ROCKET PHARMACEUTICALS, INC. | $4,839 1,592 shares | -1% | +30% from low-86% from high | |
| 36Weak | ROCKET PHARMACEUTICALS, INC. | $37k 12,109 shares | -8% | +30% from low-86% from high | |
| 30Weak | ROCKET PHARMACEUTICALS, INC. | $3,784 587 shares | -0% | +43% from low-69% from high | |
| 30Weak | ROCKET PHARMACEUTICALS, INC. | $6,175 946 shares | -1% | +36% from low-70% from high | |
| 30Weak | ROCKET PHARMACEUTICALS, INC. | $15k 1,175 shares | -2% | - |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Sep 11, 2026 | RCKT ROCKET PHARMACEUTICALS, INC. | 75,364 0.07% of outstanding | $256k | Sep 11, 2026 | $14k |
| Aug 18, 2026 | RCKT ROCKET PHARMACEUTICALS, INC. | 631 0.00% of outstanding | $2,134 | Aug 18, 2026 | $14k |
| Aug 13, 2026 | RCKT ROCKET PHARMACEUTICALS, INC. | 3,493 0.00% of outstanding | $12k | Aug 13, 2026 | $14k |
| May 19, 2026 | RCKT ROCKET PHARMACEUTICALS, INC. | 662 0.00% of outstanding | $1,996 | May 19, 2026 | $12k |
| May 13, 2026 | RCKT ROCKET PHARMACEUTICALS, INC. | 3,361 0.00% of outstanding | $12k | May 13, 2026 | $45k |
| Feb 18, 2026 | RCKT ROCKET PHARMACEUTICALS, INC. | 1,376 0.00% of outstanding | $4,594 | Feb 18, 2026 | $45k |
| Feb 13, 2026 | RCKT ROCKET PHARMACEUTICALS, INC. | 12,253 0.01% of outstanding | $41k | Feb 13, 2026 | $4,910 |
| Nov 18, 2025 | RCKT ROCKET PHARMACEUTICALS, INC. | 1,646 0.00% of outstanding | $4,910 | Nov 18, 2025 | $4,839 |
| Aug 19, 2025 | RCKT ROCKET PHARMACEUTICALS, INC. | 588 0.00% of outstanding | $1,762 | Aug 19, 2025 | $43k |
| Aug 18, 2025 | RCKT ROCKET PHARMACEUTICALS, INC. | 1,004 0.00% of outstanding | $3,077 | Aug 18, 2025 | $40k |
| Aug 14, 2025 | RCKT ROCKET PHARMACEUTICALS, INC. | 12,109 0.01% of outstanding | $37k | Aug 14, 2025 | $9,959 |
| May 20, 2025 | RCKT ROCKET PHARMACEUTICALS, INC. | 587 0.00% of outstanding | $3,784 | May 20, 2025 | $40k |
| May 16, 2025 | RCKT ROCKET PHARMACEUTICALS, INC. | 946 0.00% of outstanding | $6,175 | May 16, 2025 | $34k |
| Feb 21, 2025 | RCKT ROCKET PHARMACEUTICALS, INC. | 3,222 0.00% of outstanding | $34k | Feb 21, 2025 | $15k |
| Nov 21, 2024 | RCKT ROCKET PHARMACEUTICALS, INC. | 1,175 0.00% of outstanding | $15k | Nov 21, 2024 | none |
Transactions
Every row this insider has filed, 18 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 11, 2026 | RCKT ROCKET PHARMACEUTICALS, INC. | SOpen-market sale Common Stock | -75,364 | $3.40 | $256k | 598,489 | 28 d ago |
| Aug 18, 2026 | RCKT ROCKET PHARMACEUTICALS, INC. | SOpen-market sale Common Stock | -631 | $3.38 | $2,133 | 673,853 | Aug 20, 2026 |
| Aug 13, 2026 | RCKT ROCKET PHARMACEUTICALS, INC. | SOpen-market sale Common Stock | -3,493 | $3.38 | $12k | 674,484 | Aug 17, 2026 |
| May 19, 2026 | RCKT ROCKET PHARMACEUTICALS, INC. | SOpen-market sale Common Stock | -662 | $3.01 | $1,995 | 677,977 | May 21, 2026 |
| May 13, 2026 | RCKT ROCKET PHARMACEUTICALS, INC. | SOpen-market sale Common Stock | -3,361 | $3.61 | $12k | 678,639 | May 14, 2026 |
| Feb 18, 2026 | RCKT ROCKET PHARMACEUTICALS, INC. | SOpen-market sale Common Stock | -1,376 | $3.34 | $4,593 | 682,000 | Feb 20, 2026 |
| Feb 13, 2026 | RCKT ROCKET PHARMACEUTICALS, INC. | SOpen-market sale Common Stock | -12,253 | $3.31 | $41k | 683,376 | Feb 18, 2026 |
| Feb 11, 2026 | RCKT ROCKET PHARMACEUTICALS, INC. | AGrant or award Common Stock | +311,813 | $0.00 | $0 | 695,629 | Feb 13, 2026 |
| Feb 11, 2026 | RCKT ROCKET PHARMACEUTICALS, INC. | AGrant or award Stock Option (Right to Buy)derivative | +468,187 | $0.00 | $0 | 468,187 | Feb 13, 2026 |
| Nov 18, 2025 | RCKT ROCKET PHARMACEUTICALS, INC. | SOpen-market sale Common Stock | -1,646 | $2.98 | $4,910 | 383,816 | Nov 20, 2025 |
| Nov 3, 2025 | RCKT ROCKET PHARMACEUTICALS, INC. | AGrant or award Common Stock | +100,000 | $0.00 | $0 | 385,462 | Nov 10, 2025 |
| Sep 8, 2025 | RCKT ROCKET PHARMACEUTICALS, INC. | AGrant or award Common Stock | +150,000 | $0.00 | $0 | 285,462 | Sep 9, 2025 |
| Aug 18, 2025 | RCKT ROCKET PHARMACEUTICALS, INC. | SOpen-market sale Common Stock | -1,004 | $3.07 | $3,077 | 136,050 | Aug 20, 2025 |
| Aug 19, 2025 | RCKT ROCKET PHARMACEUTICALS, INC. | SOpen-market sale Common Stock | -588 | $3.00 | $1,762 | 135,462 | Aug 20, 2025 |
| Aug 14, 2025 | RCKT ROCKET PHARMACEUTICALS, INC. | SOpen-market sale Common Stock | -12,109 | $3.02 | $37k | 137,054 | Aug 18, 2025 |
| May 20, 2025 | RCKT ROCKET PHARMACEUTICALS, INC. | SOpen-market sale Common Stock | -587 | $6.45 | $3,784 | 149,163 | May 22, 2025 |
| May 16, 2025 | RCKT ROCKET PHARMACEUTICALS, INC. | SOpen-market sale Common Stock | -946 | $6.53 | $6,175 | 149,750 | May 20, 2025 |
| Nov 21, 2024 | RCKT ROCKET PHARMACEUTICALS, INC. | SOpen-market sale Common Stock | -1,175 | $13.05 | $15k | 63,560 | Nov 25, 2024 |
Questions about Martin Wilson
Answered from the filings on this page, as of the latest one.
Is Martin Wilson buying or selling?
In the last 12 months Martin Wilson reported 0 open-market buys worth $0 and 8 open-market sells worth $335k on SEC Form 4; the latest was sold $256k of RCKT on Sep 11, 2026. Grants, option exercises and tax withholding are not counted.
How did Martin Wilson's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Martin Wilson has 0.
Where does Martin Wilson file Form 4?
Martin Wilson has filed Form 4 at RCKT (ROCKET PHARMACEUTICALS, INC.) as General Counsel. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.